Detalhe da pesquisa
1.
Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy.
Mol Ther
; 25(8): 1917-1932, 2017 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578991
2.
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.
Nat Commun
; 15(1): 1700, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402224
3.
Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145033
4.
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity.
Mol Cancer Ther
; 20(9): 1723-1734, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224361
5.
Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer.
J Clin Invest
; 131(16)2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228641
6.
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown.
Cancer Discov
; 11(11): 2828-2845, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230008
7.
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells.
Cancer Discov
; 11(5): 1100-1117, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419761
8.
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.
Clin Cancer Res
; 26(23): 6284-6298, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817076
9.
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.
Mol Cancer Ther
; 17(5): 1024-1038, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545330
10.
Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin.
Mol Cancer Ther
; 5(12): 3122-9, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17172415
11.
Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence.
Sci Rep
; 7: 40098, 2017 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28067257
12.
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies.
Cancer Res
; 77(10): 2686-2698, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283653
13.
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist.
Clin Cancer Res
; 23(13): 3416-3427, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28069723
14.
Targeting CD73 in the tumor microenvironment with MEDI9447.
Oncoimmunology
; 5(8): e1208875, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622077
15.
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody.
Cancer Immunol Res
; 3(9): 1052-62, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943534
16.
Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.
Hum Gene Ther
; 14(8): 777-87, 2003 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12804140
17.
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
MAbs
; 6(6): 1571-84, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25484061
18.
Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
J Immunother
; 32(4): 341-52, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19342971
19.
Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.
Neoplasia
; 11(6): 509-17, 2 p following 517, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19484140
20.
Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.
J Virol
; 76(4): 1892-903, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11799184